Skip to main content
Erschienen in: Journal of Cardiothoracic Surgery 1/2023

Open Access 01.12.2023 | Research

Distal aortic biomechanics after transcatheter versus surgical aortic valve replacement: a hypothesis generating study

verfasst von: Lisa Q. Rong, William Zheng, Andrew Martinez, Mohammed Rahouma, Richard B. Devereux, Jiwon Kim, Bassam Osman, Maria C. Palumbo, Björn Redfors, Leonard N. Girardi, Jonathan W. Weinsaft, Mario Gaudino

Erschienen in: Journal of Cardiothoracic Surgery | Ausgabe 1/2023

Abstract

Background

Biomechanical effects of transcatheter (TAVR) versus surgical (SAVR) aortic valve interventions on the distal aorta have not been studied. This study utilized global circumferential strain (GCS) to assess post-procedural biomechanics changes in the descending aorta after TAVR versus SAVR.

Methods

Patients undergoing TAVR or SAVR for aortic stenosis were included. Transesophageal (TEE) and transthoracic (TTE) echocardiography short-axis images of the aorta were used to image the descending aorta immediately before and after interventions. Image analysis was performed with two-dimensional speckle tracking echocardiography and dedicated software. Delta GCS was calculated as: post-procedural GCS—pre-procedural GCS. Percentage delta GCS was calculated as: (delta GCS/pre-procedural GCS) × 100.

Results

Eighty patients, 40 TAVR (median age 81 y/o, 40% female) and 40 SAVR (median 72 y/o, 30% female) were included. The post-procedure GCS was significantly higher than the pre-procedural GCS in the TAVR (median 10.7 [interquartile range IQR 4.5, 14.6] vs. 17.0 [IQR 6.1, 20.9], p = 0.009) but not in the SAVR group (4.4 [IQR 3.3, 5.3] vs. 4.7 [IQR 3.9, 5.6], p = 0.3). The delta GCS and the percentage delta GCS were both significantly higher in the TAVR versus SAVR group (2.8% [IQR 1.4, 6] vs. 0.15% [IQR − 0.6, 1.5], p < 0.001; and 28.8% [IQR 14.6%, 64.6%] vs. 4.4% [IQR − 10.6%, 5.6%], p = 0.006). Results were consistent after multivariable adjustment for key clinical and hemodynamic characteristics.

Conclusions

After TAVR, there was a significantly larger increase in GCS in the distal aorta compared to SAVR. This may impact descending aortic remodeling and long-term risk of aortic events.

Introduction

Surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) are the standard treatments for severe aortic stenosis (AS). Previous studies have demonstrated similar efficacy and short- to mid-term outcomes for patients who undergo SAVR and TAVR [15] but the differential impact of the two procedures on aortic biomechanics is not well understood. Aortic stenosis can be associated with concurrent aortopathy, and changes in aortic energy propagation after SAVR versus TAVR may affect distal aneurysm growth and aortic disease progression particularly in patients with genetic aortopathies or bicuspid aortic valve (BAV).
Global circumferential aortic strain (GCS) is a measure of arterial stiffness and aortic biomechanics that can derived from standard two-dimensional echocardiographic images of the aorta [69]. This measure can assess the deformation of the aortic wall between end-diastole and peak-systole and has been validated against the gold standard cardiac magnetic resonance [7, 10]. Previous studies have used GCS to evaluate distal aortic biomechanics after aortic valve and ascending aorta replacement in cardiac surgical patients. However, changes in distal aortic biomechanics after TAVR and SAVR have yet to be characterized. This hypothesis-generating study utilized echo-derived GCS to assess changes in distal aortic biomechanics after TAVR and SAVR. We hypothesized that TAVR would increase GCS compared to SAVR due to the larger device footprint compared to the bioprosthetic surgical valves.

Methods

The study was approved by the Weill Cornell Institutional Review Board (IRB number 20-0102134). Patients that underwent TAVR or SAVR for severe isolated aortic stenosis were prospectively enrolled and consented between January 2021 and March 2023. This was a hypothesis generating study, and no formal sample size calculation was performed. All patients met clinical criteria for aortic valve intervention due to severe AS as determined by a multidisciplinary team of cardiac surgeons, cardiologists, and echocardiographers. Patients with more than mild valvular regurgitation (aortic, tricuspid, or mitral) were excluded, as were those aborted intervention (TAVR), and with inadequate imaging for strain analysis were excluded.
SAVR was performed through full sternotomy and cardiopulmonary bypass using bioprosthetic valves, with size and valve type listed in Table 1.
Table 1
Population characteristics
 
Overall
(n = 80)
SAVR
(n = 40)
TAVR
(n = 40)
p
Clinical characteristics
    
Age [year (median IQR)]
76.5 [70,83]
72 [63,75]
81 [74,88]
 < 0.001
Blood pressure (mm Hg)
    
Male gender
52 (65)
28 (70)
24 (60)
0.48
Bicuspid aortic valve
16 (20)
13 (32.5)
3 (7.5)
0.012
Pre-AVR AS severity
   
1
 Moderate
1 (1.2)
1 (2.5)
0
 
 Severe
79 (98.8)
39 (97.5)
40 (100)
 
Clinical risk factors
    
Coronary artery disease
32 (40)
12 (30)
20 (50)
0.11
Hypertension
57 (71.2)
26 (65)
31 (77.5)
0.32
Hyperlipidemia
51 (63.7)
24 (60)
27 (67.5)
0.64
Diabetes mellitus
18 (22.5)
8 (20)
10 (25)
0.77
NYHA ≥ 2
68 (85)
29 (72.5)
39 (97.5)
0.005
Intraoperative data
    
Valve size (mm, median [IQR])
25 [23,26]
23 [23,25]
26 [23,29]
 < 0.001
Edwards (Magna/Inspiris resilia; Sapien 3)
 
33 (82.5)
35 (87.5)
 
Medtronic (Mosaic Valve/Avalus; Core valve)
 
7 (17.5)
5 (12.5)
 
Mean gradient
    
 Pre-AVR
40.5 [30.2,47]
38.8 [29.8,45.5]
41 [33.6,47.7]
0.33
 post-AVR
6 [4, 9]
8 [5.5,11]
4 [3, 6]
 < 0.001
Pulse pressure
    
Use of inotropes*
29 (36.2)
27 (67.5)
2 (5)
 < 0.001
Use of vasopressors**
23 (29.1)
9 (23.1)
14 (35)
0.36
AVR Aortic valve replacement, IQR Inter-quartile range, NYHA New York Heart Failure Association, SAVR Surgical aortic valve replacement, TAVR Transcatheter aortic valve replacement
*Inotropes = epinephrine, milrinone, dobutamine infusions
**Vasopressors = vasopressin, norepinephrine, phenylephrine infusions
All intraoperative transesophageal echocardiography (TEE) and/or transthoracic echocardiography (TTE) images were prospectively acquired via a standard imaging protocol using clinical equipment (EPIQ 7, Philips Medical Systems [Andover, MA] ultrasound systems). For SAVR, intraoperative TEE images were captured with stable hemodynamics immediately after induction and before incision (pre-procedure), and after chest closure (post-procedure) as previously described [6]. For TAVR, TEE and TTE echo exams were performed with stable hemodynamics before procedure start (pre-procedure), and after valve deployment (post-procedure). Hemodynamic variables including cardiac output and cardiac index were obtained at the time of the echo exams via a pulmonary artery catheter. Pulse pressure was derived from the arterial blood pressure.

Aortic global circumferential strain

TEE and TTE images were used to capture short-axis images of the descending aorta before and after valve replacement. Images were analyzed by two experts blinded to patient data but not to modality. GCS was used to measure the change in circumferential deformation in the aortic short axis images using speckle-tracking of the aortic wall using dedicated software (Qlab version 10.8.5, Philips Healthcare, Amsterdam, Netherlands) as previously described [6]. Briefly, a center point was placed within the aorta in addition to an inner and outer circle that approximated the endothelial and adventitial surfaces of the aorta during the end-diastolic frame, allowing for tracking of the aortic wall throughout the cardiac cycle, and the width was adjusted to contain the entire wall thickness of the aorta. Automatically generated strain measurements were then evaluated for optimal border tracking. If the software output did not adequately track the aortic wall and/or the generated strain curve was not smooth, the inner and outer circles were adjusted circumferentially in the end-diastolic and end-systolic frames to enhance border tracking [6, 9, 11].
The 6 sub-segments of the aorta were averaged to measure the following aortic biomechanical variables:
  • Global circumferential aortic strain (GCS) maximal deformation of the aortic circumference between systole and diastole (measured as the relative (%) difference between these two time points; [end-systole–end-diastole]/end-diastole*100).
  • Change in GCS (Delta GCS) post-procedure GCS-pre-procedure GCS.
  • Relative change in GCS (Percent Change GCS) post-procedure GCS-pre-procedure GCS/pre-procedure GCS × 100
  • Pulse-Pressure Adjusted GCS GCS divided by pulse pressure (PP):(GCS/PP)
  • Time to peak (TTP) strain calculated as time interval between end-diastole (aortic valve opening) and average peak global circumferential aortic strain.
Aortic end-systolic area (ESA) and end-diastolic area (EDA) were also measured and used to calculate fractional area change (FAC) of the aorta (FAC = [ESA − EDA]/ESA). Aortic distensibility index was calculated via well-validated method; [(ESA − EDA)/(ESA)(PP)] [12].
Figure 1 provides a representative example of aortic analyses performed pre- and post-SAVR and TAVR.

Statistical analyses

Categorical variables were reported as counts and percentages. Normality of continuous variables was determined by the Shapiro-Wilkinson test. Normally distributed data were reported as mean ± standard deviation (SD) and non-normally distributed variables were reported as median and interquartile ranges (IQR).
The Student’s t-test was employed to assess differences between groups with normally distributed variables and the Mann–Whitney U test was used if variables were non-normally distributed. Chi squared and Fisher’s exact tests were used for categorical variables, as appropriate.
To adjust for potential differences in baseline characteristics and imaging methods between patients, analysis of covariance (ANCOVA) was used to assess the difference of delta GCS and percentage change GCS between groups. Adjustment for key baseline and hemodynamic variables included age, sex, baseline GCS, valve type [bicuspid, tricuspid], NYHA class, use of inotropes/vasopressors, preoperative systolic and diastolic blood pressure, preoperative CI and postoperative CI, preoperative aortic stenosis severity, and post-procedure aortic valve mean gradient. Results of ANCOVA were expressed as mean and standard error and visually as effect plots that showed mean and 95% confidence intervals.
Two-sided p < 0.05 was considered statistically significant without multiplicity adjustment. Analysis was performed using R version 3.6.1 within RStudio. Two sensitivity analyses were performed: (1) repeating the main analyses including only patients with trileaflet aortic valve (BAV patients were excluded to reduce possible heterogeneity due to valve morphology) and (2) adding imaging modality (TEE vs. TEE) to the ANCOVA multivariable analysis (to reduce possible heterogeneity due to different imaging techniques).

Results

Eighty patients (40 TAVR and 40 SAVR) were included in the study cohort (see Fig. 2 for details of patient inclusion); the median age of the included patients was 76.5 years (IQR 70–83), 65% were men, 20% had bicuspid aortic valves. Baseline and intra-procedural characteristics of patients in the two groups are summarized in Table 1.
In the TAVR group, the transfemoral approach was used in 39/40 patients (97.5%) while in one patient the left subclavian approach was used. The TAVR valves implanted were Edward Sapien 3 (35/40, 87.5%) and Medtronic Core valve (5/40, 12.5%). In the SAVR group, all surgeries were performed open sternotomy with cardiopulmonary bypass and implanted 82.5% Edwards Lifesciences (PERIMOUNT Magna™ and INSPIRIS™ RESILIA valves), and 17.5% Medtronic (Mosaic™, Avalus Bovine Aortic Surgical Valves), based on surgeon preference.

Aortic global circumferential strain (GCS)

The change in GCS (Delta GCS, pre vs. post-procedure GCS) was significant in the TAVR (median 10.7 [IQR 4.5, 14.6] vs. 17.0 [IQR 6.1, 20.9], p = 0.009) but not in in the SAVR group (4.4 [IQR 3.3, 5.3] vs. 4.7 [IQR 3.9, 5.6], p = 0.3) (Table 2); the delta GCS was significantly higher in the TAVR group compared to the SAVR group: 2.8% [IQR 1.4, 6] vs. 0.15% [IQR − 0.6, 1.5], p < 0.001 (Table 4). The percentage delta GCS was also significantly greater in the TAVR versus SAVR group (28.8% [IQR 14.6, 64.6] vs. 4.4% [IQR − 10.6, 56], p = 0.006). (Table 3).
Table 2
Descending Aortic Biomechanics Before and After Interventions
 
SAVR (n = 40)
TAVR (n = 40)
 
Pre
Post
p
Pre
Post
p
Global circumferential strain, GCS [%]
4.4 [3.3,5.3]
4.7 [3.9,5.6]
0.32
10.7 [4.5,14.6]
17.0 [6.1,20.9]
0.009
Pulse pressure corrected strain [%/mm Hg] (GCS/PP)
6.8 [5.5,9.2]
7.6 [6.1,10.8]
0.20
13.6 [8.6,23.5]
26.8 [10.6,32.0]
0.012
Time to peak strain, TTP [ms]
300 [270,334]
195 [167,250]
 < 0.001
315 [285,400]
300 [280,385]
0.33
Δ Αrea/TTP [cm2/s]
1.3 [0.9,1.9]
2.5 [1.8,3.1]
 < 0.001
2.2 [1.5,3.7]
2.6 [1.8,4.2]
0.22
Distensibility [10–3 mmHg−1]
1.5 [1.1,2.0]
1.4 [1.1,1.7]
0.52
3.6 [1.9,6.7]
4.9 [1.4,7.6]
0.76
Δ Αrea [cm2]
0.4 [0.3,0.6]
0.5 [0.4,0.6]
0.11
0.9 [0.4,1.2]
0.7 [0.6,1.4]
0.53
Fractional area change [%]
9.4 [6.8,11.9]
10.5 [9.3,13.5]
0.09
30.0 [9.1,40.8]
32.9 [103,57.1]
0.22
End systolic area [cm2]
5.3 [4.1,5.9]
4.8 [4.1,6.0]
0.81
4.6 [3.7,5.6]
4.4 [3.3,5.7]
0.90
End diastolic area [cm2]
4.8 [3.7,5.7]
4.3 [3.6,5.4]
0.65
3.3 [2.6,4.9]
3.3 [2.5,4.7]
0.76
cm centimeters, GCS Global circumferential strain [%], ms milliseconds, PP pulse pressure, SAVR surgical aortic valve replacement, TAVR transcatheter aortic valve replacement, TTP, time to peak
Table 3
Absolute (delta) and relative (percentage change) differences before and after interventions after adjustment for key variables
 
Overall
(n = 80)
SAVR
(n = 40)
TAVR
(n = 40)
P
Delta GCS
1.5 [− 0.1,3.4]
0.15 [− 0.6,1.5]
2.8 [1.4,6]
 < 0.001
Delta GCS/PP
3.05 [− 0.01,7.7]
1.3 [− 1.5,3.2]
6.1 [1.6,12.3]
 < 0.001
Delta GCS (Mean (SE)) *
0.2 (0.9)
4.2 (0.9)
0.011
Delta GCS/PP (Mean (SE)) *
0.5(2.1)
9.2 (2.1)
0.024
Percent change GCS
21.2 [− 2.3,58]
4.4 [− 10.6,56]
28.8 [14.6,64.6]
0.006
Percent change GCS (GCS/PP)
31.9 [0.14,78.8]
18.4 [− 27.4,46.4]
36.9 [11.2,83]
0.11
Percent change GCS ((Mean (SE)) *
 − 1.8 (13.3)
62.0 (13.3)
0.010
Percent change GCS/PP (Mean (SE)) *
9.5 (18.4)
81.6 (18.4)
0.035
Delta EDA
 − 0.1 [− 0.6,0.3]
 − 0.04 [− 0.36,0.36]
 − 0.25 [− 0.8,0.3]
0.37
Delta ESA
 − 0.1 [− 0.5,0.5]
 − 0.02 [− 0.36,0.6]
 − 0.2 [− 0.7,0.26]
0.38
Delta FAC
1.6 [− 1.8,6.1]
1.3 [− 0.5,4.7]
1.9 [− 2.1,14.1]
0.45
All values were (median [interquartile range]) except for mean and SE
*ANCOVA Adjusted. SE standard error, cm centimeters, EDA End diastolic area, ESA End systolic area, FAC Fractional area change, GCS Global circumferential strain [%], ms Milliseconds, PP Pulse pressure, SAVR Surgical aortic valve replacement, TAVR Transcatheter aortic valve replacement, TTP Time to peak
The pulse-pressure corrected GCS was significantly higher post-procedure in the TAVR (13.6% [IQR 8.6, 23.5] vs. 26.8% [IQR 10.6, 32], p = 0.012) but not in the SAVR group (6.8% [IQR 5.5, 9.2] vs. 7.6% [IQR 6.1, 10.8], p = 0.2). The pulse-pressure corrected delta GCS was also significantly greater in the TAVR compared to the SAVR group (6.1% [IQR 1.6, 12.3] vs. 1.3% [IQR − 1.5, 3.2], p < 0.001). (Table 3).
In the fully adjusted ANCOVA model, the delta GCS and the percentage delta GCS were both significantly greater in the TAVR compared to the SAVR group (0.2% ± 0.8 vs. 4.2% ± 0.8, p < 0.001 and − 1.8% ± 13.3 vs. 62.0% ± 13.3, p < 0.010 respectively, Table 3, Fig. 3). The delta GCS/PP and percentage delta GCS/PP were also significantly greater in the TAVR versus SAVR groups (0.5% ± 2.1 vs. 9.2% ± 2.1), p < 0.024, and 9.5% ± 18.4) vs. 81.6% ± 18.4, p < 0.035).
In the sensitivity analysis excluding BAV patients, both delta GCS and percentage delta GCS remained significantly greater after TAVR versus SAVR before and after ANCOVA with adjustment for key variable (Additional file 1: Tables S1 and S2). In the sensitivity analysis adjusted by imaging modality, the results remained solid after accounting for imaging modality in the multivariable ANCOVA model (TEE vs. TTE) (Additional file 1: Table S3).

Other measures

Post-procedure TTP and distensibility were significantly higher in the TAVR group (300 ms [IQR 280, 385] vs. 195 ms [IQR 166.8, 250], and 4.9 (10−3 mmHg) [IQR 1.4, 7.6] vs. 1.4 (10−3 mmHg) [IQR 1.1, 1.7], p < 0.001 for both—Table 4).
Table 4
Biomechanical variables before and after interventions
 
Overall
(n = 80)
SAVR
(n = 40)
TAVR
(n = 40)
P
Pre-procedure strain variables
    
 GCS (%)
5.2 [3.4,10.7]
4.4 [3.3,5.3]
10.7 [4.5,14.6]
 < 0.001
 Pulse pressure-corrected strain (GCS/PP)
9.1 [6.3,14.6]
6.8 [5.5,9.2]
13.6 [8.6,23.5]
 < 0.001
 TTP (ms)
300 [270,370.3]
300 [270,334]
315 [285,400]
0.14
 ΔΑrea/TTP [cm2/s]
1.7 [1.04,2.5]
1.3 [0.9,1.9]
2.2 [1.5,3.7]
0.001
Distensibility (10−3 mmHg)
2 [1.3,4.2]
1.5 [1.1,2.04]
3.6 [1.9,6.7]
 < 0.001
 FAC (%)
10.7 [7.4,29.8]
9.35 [6.8,11.9]
30 [9.4,40.8]
 < 0.001
 ESA (cm2)
4.8 [3.8,5.7]
5.3 [4.07,5.9]
4.6 [3.7,5.6]
0.12
 EDA (cm2)
4.1 [3.1,5.3]
4.8 [3.7,5.6]
3.3 [2.6,4.9]
0.002
Post-procedure strain variables
    
 GCS (%)
5.6 [4.1,16.23]
4.65 [3.9,5.6]
17 [6.1,20.9]
 < 0.001
 Pulse pressure-corrected strain (GCS/PP %)
10.8 [6.3,26.5]
7.6 [6.1,10.8]
26.8 [10.6,32]
 < 0.001
 TTP (ms)
263.5 [187.5,305]
195 [166.8,250]
300 [280,385]
 < 0.001
 Δ Αrea/TTP [cm2/s]
2.6 [1.8,3.6]
2.5 [1.8,3.1]
2.6 [1.8,4.2]
0.26
 PP (mmHg)
61 [47.8,72.3]
60 [46.8,67.5]
63 [50.8,77]
0.08
Distensibility (10−3 mmHg)
1.6 [1.2,4.95]
1.4 [1.1,1.7]
4.9 [1.4,7.6]
 < 0.001
 FAC (%)
12.3 [9.5,35.2]
10.5 [9.3,13.5]
32.9 [10.3,57.1]
 < 0.001
 ESA (cm2)
4.6 [3.7,5.9]
4.8 [4.1,6.0]
4.3 [3.3,5.7]
0.14
 EDA (cm2)
3.9 [2.9,5]
4.3 [3.6,5.4]
3.3 [2.5,4.7]
0.002
All values were (median [interquartile range])
cm Centimeters, EDA End diastolic area, ESA End systolic area, FAC Fractional area change, GCS Global circumferential strain [%], ms Milliseconds, PP Pulse pressure, SAVR Surgical aortic valve replacement, TAVR Transcatheter aortic valve replacement, TTP Time to peak
There were no significant differences between the pre and post-procedure delta GCS/PP, delta EDA, delta ESA, and delta FAC, delta area, or aortic ESA and conventional imaging variables between the TAVR and SAVR groups (Tables 3, 4).
Hemodynamics and measures of left ventricular function in the two groups at the different timepoints are presented in Table 5.
Table 5
Hemodynamic variables before and after interventions
 
Overall
(n = 80)
SAVR
(n = 40)
TAVR
(n = 40)
P
Pre-procedure hemodynamics
HR (bpm) (median [IQR])
63.5 [56.7,72]
60 [55.75,70.25]
65.5 [59,73.2]
0.10
SBP (mmHg)
122 [110.5,138]
122 [110.2,134]
122 [110.5,145]
0.57
DBP (mmHg)
58 [52,65]
60 [52.7,65]
57 [51,64]
0.29
PP (mmHg)
63.5 [51.8,78]
61 [50,75]
69 [56, 79]
0.14
EDV (ml)
109.9 [87,132.7]
106.59 [80.8,119.4]
123.93 [91.85,163.9]
0.021
ESV (ml)
42.4 [31.02,57.02]
38.1 [27.9,49.8]
42.8 [35.08,69.16]
0.049
EF (%)
62.5 [55, 66.5]
60 [59.1,67.2]
62.5 [47.9,65.5]
0.46
SV (ml)
67.6 [53.02,80.2]
61.8 [52.3,72.68]
70 [58.27,84.2]
0.09
CO (L/min)
4.2 [3.4,5.06]
3.7 [3.16,4.7]
4.4 [3.7,5.6]
0.025
CI (L/min/m2)
2.3 [1.85,2.6]
2.03 [1.7,2.37]
2.5 [2.09,2.8]
 < 0.001
Post-procedure hemodynamics
HR (bpm) (median [IQR])
69.5 [63.7,80]
77 [69,84]
64.5 [60.7,71.5]
 < 0.001
SBP (mmHg)
115.5 [103.7,131]
115.5 [102.7,129.5]
116 [104.75,132]
0.54
DBP (mmHg)
56 [51,62.5]
57.5 [51.75,66.5]
54.5 [49.5,60]
0.17
EDV (ml)
93.6 [74.9,130.4]
87.9 [65.32,101.5]
120.6 [90.67,141.05]
 < 0.001
PP (mmHg)
61 [47.8,72.3]
60 [46.8,67.5]
63 [50.8,77]
0.08
ESV (ml)
25.8 [16.35,50.75]
21.2 [15.7,38.3]
34.3 [19.3,56.3]
0.059
EF (%)
67 [59,84]
69 [60,84.5]
66.5 [56.75,84]
0.69
SV (ml)
70.9 [54.76,83.7]
59.5 [46.16,73.8]
77.9 [66.6,96.5]
 < 0.001
CO (L/min)
5.09 [4.07,6.1]
4.89 [3.9,5.89]
5.2 [4.38,6.1]
0.56
CI (L/min/m2)
2.7 [2.16,3.38]
2.67 [2.09,3.1]
2.8 [2.3,3.49]
0.14
All values were (median [interquartile range])
bpm Beats per minute, CI Cardiac index, cm Centimeters, CO Cardiac output, DBP Diastolic blood pressure, EDV End diastolic volume, EF Ejection fraction, ESV End systolic volume, HR Heart rate, IQR Inter-quartile range, L/min Liters/minute, m Meters, ml Milliliter, mmHg Millimeters mercury, ms Milliseconds, SAVR Surgical aortic valve replacement, SBP Systolic blood pressure, TAVR Transcatheter aortic valve replacement

Discussion

This study found that the absolute and relative change in circumferential strain in the descending aorta after aortic valve interventions was significantly greater after TAVR than after SAVR. This was confirmed after adjustment for key variables including baseline GCS, age, sex, blood pressure, pre and post-procedure cardiac index and aortic valve gradient. Our hypothesis-generating results suggest that TAVR implantation is associated with increased energy propagation to the descending aorta and with a potentially increased risk of post-procedural adverse aortic events compared to SAVR. This hypothesis is clinically important given the ongoing trend to expand TAVR interventions to a younger population and to patients with BAV who are more susceptible to aortic events.
A study using the National Inpatient Sample found that the percentage of patients ≤ 65 years old undergoing TAVR increased from 2012 to 2015, from 1.2 to 3.5% in the ≤ 55-year group, and from 2.5 to 7.3% in the 55–65 year age group [13]. In another study based on the Transcatheter Valve Therapy Registry of over 160,000 patients, the proportion of patients at low surgical risk who underwent TAVR increased from 9.6% in 2015 to 43.8% in 2020 and the proportion of patients with BAV undergoing TAVR increased from 2.8% in 2015 to 6.8% in 2020 [14].
While previous studies have shown that the relative survival of patients with bicuspid AS who underwent SAVR is excellent and comparable to a matched general population, [15] no similar data exist for patients with BAV who undergo TAVR [15]. This study evaluating differential impact of TAVR versus SAVR on the aorta is important considering the known higher risk of aortic dissection and acute aortic events in BAV patients [16].
These findings also have implications for patients with concomitant ascending aortic aneurysms undergoing TAVR. One group reported that over 25% of their patients undergoing TAVR had ascending aortic aneurysms of 4 to 5 cm [17]. At a mean follow-up of 14 months, the authors found comparable intraprocedural safety between the aneurysm and non-aneurysm groups and found that ascending aortic diameters remained stable in their relatively old, non-BAV population. However, it is unclear if this would be true in younger patients or in a BAV population at longer follow-up. It should be considered that our data were recorded during sedation and anesthesia, and it is reasonable to believe that the difference in energy propagation between groups is magnified during exercise (an issue of particular relevance in the young and active patient population).
Circumferential strain has been used to study aortic physiology in cardiac surgical populations and allows for accurate quantification of arterial biomechanics [69]. Circumferential strain is the change or displacement of the circumference from its baseline value and is quantified by the percentage change in circumference between the aorta at baseline and during systolic deformation. Circumferential strain of the aorta from two-dimensional TEE or TTE echo images can be calculated over the circumference of the aortic wall in the short axis view over the cardiac cycle as a measure of energy propagation [10].
Previous studies have used GCS to investigate the acute impact of ascending aortic graft replacement on descending aorta biomechanics, and the effect on the distal aorta of SAVR for aortic stenosis versus aortic insufficiency [6]. Other studies have shown that flow patterns in the ascending aorta after SAVR may be different using different aortic valve prostheses [18]. A study by Bisell et al. evaluated flow patterns and wall stress on the proximal aorta after mechanical versus bioprosthetic SAVR and found decreased wall stress with mechanical valves and suggested this as potential mechanism for future aneurysm formation [19].
There are several potential reasons why TAVR valves may result in greater energy propagation to the distal aorta compared to SAVR. One is that TAVR devices, either self-expanding or balloon-expandable, differ from surgical valves by containing a valve within a metal frame, which serves to anchor the device in the annulus and proximal ascending aorta without sutures. These caged prostheses differ from the native aorta in geometry and compliance, and likely interfere with the pressure-regulating effect of the ascending aorta (Windkessel effect) alter pulse wave propagation and cause high velocity flow to distal segments of the aorta, providing potential for adverse remodeling and dissection [20, 21]. Another possible reason is that TAVR valves have a lower profile and increased effective orifice areas compared to surgical valves, allowing higher stroke volume [22] and distal energy propagation.
The possibility of a different effect of TAVR versus SAVR on post-procedural aortic biomechanics and potentially on the risk of aneurysm development among patients with AS is a clinically important question in an era in which TAVR indications expand to patients with bicuspid aortic valve and to young patients with long life expectancy. The increase in distal energy propagation after TAVR versus SAVR may accelerate aneurysm growth, especially in high-risk populations and may require dedicated follow-up imaging surveillance after the procedure [23].
This study has several limitations. First, this is a hypothesis-generating study, and no formal sample size calculation was performed. The TAVR group used mostly TTE to evaluate the differences in GCS in the descending aorta while the SAVR group used TEE. While both have been validated for imaging of the descending aorta, we addressed this potential confounder by evaluating the relative percentage change in strain and using ANCOVA, a statistical approach that accounts for different baseline aortic strain values. The two patient groups were different in a number of variables at baseline and intraprocedural timepoints. However, we adjusted for all key baseline clinical and hemodynamic variables and found that delta GCS and the percentage change in delta GCS remained significantly greater in the TAVR group. We also performed a sensitivity analysis accounting for imaging modality in the multivariable model (TEE vs. TTE) which supported our primary results. Also, the absolute differences in GCS between groups were large, and unlikely explained only by unaccounted confounders. Finally, our findings are limited to the time immediately post-procedure and further studies are needed to longitudinally explore the changes in the distal aorta after TAVR versus SAVR.

Conclusions

This is the first study to evaluate distal aortic biomechanics after TAVR vs. SAVR. We found that the increase in post-procedure energy propagation to the distal aorta was significantly greater after TAVR even after adjustment for important confounders.
These findings suggest that TAVR has differential downstream effects on aortic deformation and flow compared to SAVR and this may have potentially important implications for the risk of post-procedural aortic events, especially in high-risk categories of patients. Due to the growing adoption of TAVR in young patients and in patients with BAV, further studies on this topic are urgently needed.

Acknowledgements

Not applicable.

Declarations

This study was approved by the Weill Cornell Institutional Review Board (IRB Number: 20–0102134).
All patients provided informed consent.

Competing interests

The authors declare no competing interest.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382(9):799–809.CrossRefPubMed Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382(9):799–809.CrossRefPubMed
2.
Zurück zum Zitat Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15.CrossRef Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15.CrossRef
3.
Zurück zum Zitat Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.CrossRefPubMed Reardon MJ, Van Mieghem NM, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.CrossRefPubMed
4.
Zurück zum Zitat Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187–98.CrossRefPubMed
5.
Zurück zum Zitat Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.CrossRefPubMed Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.CrossRefPubMed
6.
Zurück zum Zitat Rong LQ, Palumbo MC, Rahouma M, Devereux RB, Kim J, Pryor KO, et al. Differential effects of aortic valve replacement on aortic circumferential strain in aortic stenosis and aortic insufficiency. J Cardiothorac Vasc Anesth. 2021;35(9):2707–14.CrossRefPubMed Rong LQ, Palumbo MC, Rahouma M, Devereux RB, Kim J, Pryor KO, et al. Differential effects of aortic valve replacement on aortic circumferential strain in aortic stenosis and aortic insufficiency. J Cardiothorac Vasc Anesth. 2021;35(9):2707–14.CrossRefPubMed
7.
Zurück zum Zitat Rong LQ, Palumbo MC, Rahouma M, Lopes AJ, Devereux RB, Kim J, et al. Descending aortic strain quantification by intra-operative transesophageal echocardiography: multimodality validation via cardiovascular magnetic resonance. Echocardiography. 2020;37(11):1820–7.CrossRefPubMed Rong LQ, Palumbo MC, Rahouma M, Lopes AJ, Devereux RB, Kim J, et al. Descending aortic strain quantification by intra-operative transesophageal echocardiography: multimodality validation via cardiovascular magnetic resonance. Echocardiography. 2020;37(11):1820–7.CrossRefPubMed
8.
Zurück zum Zitat Palumbo MC, Rong LQ, Kim J, Navid P, Sultana R, Butcher J, et al. Prosthetic aortic graft replacement of the ascending thoracic aorta alters biomechanics of the native descending aorta as assessed by transthoracic echocardiography. PLoS ONE. 2020;15(3):e0230208.CrossRefPubMedCentralPubMed Palumbo MC, Rong LQ, Kim J, Navid P, Sultana R, Butcher J, et al. Prosthetic aortic graft replacement of the ascending thoracic aorta alters biomechanics of the native descending aorta as assessed by transthoracic echocardiography. PLoS ONE. 2020;15(3):e0230208.CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Rong LQ, Palumbo MC, Rahouma MM, Meineri M, Arguelles GR, Kim J, et al. Immediate of impact prosthetic graft replacement of the ascending aorta on circumferential strain in the descending aorta. J Vasc Surg. 2019;70(5):1722.CrossRef Rong LQ, Palumbo MC, Rahouma MM, Meineri M, Arguelles GR, Kim J, et al. Immediate of impact prosthetic graft replacement of the ascending aorta on circumferential strain in the descending aorta. J Vasc Surg. 2019;70(5):1722.CrossRef
10.
Zurück zum Zitat Rong LQ, Kim J, Gregory AJ. Speckle tracking echocardiography: imaging insights into the aorta. Curr Opin Cardiol. 2020;35(2):116–22.CrossRefPubMed Rong LQ, Kim J, Gregory AJ. Speckle tracking echocardiography: imaging insights into the aorta. Curr Opin Cardiol. 2020;35(2):116–22.CrossRefPubMed
11.
Zurück zum Zitat Alreshidan M, Shahmansouri N, Chung J, Lash V, Emmott A, Leask RL, Lachapelle K. Obtaining the biomechanical behavior of ascending aortic aneurysm via the use of novel speckle tracking echocardiography. J Thorac Cardiovasc Surg. 2017;153(4):781–8.CrossRefPubMed Alreshidan M, Shahmansouri N, Chung J, Lash V, Emmott A, Leask RL, Lachapelle K. Obtaining the biomechanical behavior of ascending aortic aneurysm via the use of novel speckle tracking echocardiography. J Thorac Cardiovasc Surg. 2017;153(4):781–8.CrossRefPubMed
12.
Zurück zum Zitat Voges I, Jerosch-Herold M, Hedderich J, Pardun E, Hart C, Gabbert DD, et al. Normal values of aortic dimensions, distensibility, and pulse wave velocity in children and young adults: a cross-sectional study. J Cardiovasc Magn Reson. 2012;14(1):77.CrossRefPubMedCentralPubMed Voges I, Jerosch-Herold M, Hedderich J, Pardun E, Hart C, Gabbert DD, et al. Normal values of aortic dimensions, distensibility, and pulse wave velocity in children and young adults: a cross-sectional study. J Cardiovasc Magn Reson. 2012;14(1):77.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Sedrakyan A, Dhruva SS, Sun T, Mao J, Gaudino MFL, Redberg RF. Trends in use of transcatheter aortic valve replacement by age. JAMA. 2018;320(6):598–600.CrossRefPubMedCentralPubMed Sedrakyan A, Dhruva SS, Sun T, Mao J, Gaudino MFL, Redberg RF. Trends in use of transcatheter aortic valve replacement by age. JAMA. 2018;320(6):598–600.CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Makkar RR, Yoon S-H, Chakravarty T, Kapadia SR, Krishnaswamy A, Shah PB, et al. Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke among patients at low surgical risk. JAMA. 2021;326(11):1034.CrossRefPubMedCentralPubMed Makkar RR, Yoon S-H, Chakravarty T, Kapadia SR, Krishnaswamy A, Shah PB, et al. Association between transcatheter aortic valve replacement for bicuspid vs tricuspid aortic stenosis and mortality or stroke among patients at low surgical risk. JAMA. 2021;326(11):1034.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Glaser N, Jackson V, Eriksson P, Sartipy U, Franco-Cereceda A. Relative survival after aortic valve surgery in patients with bicuspid aortic valves. Heart. 2021;107(14):1167–72.CrossRefPubMed Glaser N, Jackson V, Eriksson P, Sartipy U, Franco-Cereceda A. Relative survival after aortic valve surgery in patients with bicuspid aortic valves. Heart. 2021;107(14):1167–72.CrossRefPubMed
16.
Zurück zum Zitat Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA. 2011;306(10):1104.CrossRefPubMed Michelena HI, Khanna AD, Mahoney D, Margaryan E, Topilsky Y, Suri RM, et al. Incidence of aortic complications in patients with bicuspid aortic valves. JAMA. 2011;306(10):1104.CrossRefPubMed
17.
Zurück zum Zitat Rylski B, Szeto WY, Bavaria JE, Walsh E, Anwaruddin S, Desai ND, et al. Transcatheter aortic valve implantation in patients with ascending aortic dilatation: safety of the procedure and mid-term follow-up. Eur J Cardiothorac Surg. 2014;46(2):228–33.CrossRefPubMed Rylski B, Szeto WY, Bavaria JE, Walsh E, Anwaruddin S, Desai ND, et al. Transcatheter aortic valve implantation in patients with ascending aortic dilatation: safety of the procedure and mid-term follow-up. Eur J Cardiothorac Surg. 2014;46(2):228–33.CrossRefPubMed
18.
Zurück zum Zitat von Knobelsdorff-Brenkenhoff F, Trauzeddel RF, Barker AJ, Gruettner H, Markl M, Schulz-Menger J. Blood flow characteristics in the ascending aorta after aortic valve replacement–a pilot study using 4D-flow MRI. Int J Cardiol. 2014;170(3):426–33.CrossRef von Knobelsdorff-Brenkenhoff F, Trauzeddel RF, Barker AJ, Gruettner H, Markl M, Schulz-Menger J. Blood flow characteristics in the ascending aorta after aortic valve replacement–a pilot study using 4D-flow MRI. Int J Cardiol. 2014;170(3):426–33.CrossRef
19.
Zurück zum Zitat Bissell MM, Loudon M, Hess AT, Stoll V, Orchard E, Neubauer S, Myerson SG. Differential flow improvements after valve replacements in bicuspid aortic valve disease: a cardiovascular magnetic resonance assessment. J Cardiovasc Magn Reson. 2018;20(1):10.CrossRefPubMedCentralPubMed Bissell MM, Loudon M, Hess AT, Stoll V, Orchard E, Neubauer S, Myerson SG. Differential flow improvements after valve replacements in bicuspid aortic valve disease: a cardiovascular magnetic resonance assessment. J Cardiovasc Magn Reson. 2018;20(1):10.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Galea N, Piatti F, Sturla F, Weinsaft JW, Lau C, Chirichilli I, et al. Novel insights by 4D Flow imaging on aortic flow physiology after valve-sparing root replacement with or without neosinuses†. Interact Cardiovasc Thorac Surg. 2018;26(6):957–64.CrossRefPubMed Galea N, Piatti F, Sturla F, Weinsaft JW, Lau C, Chirichilli I, et al. Novel insights by 4D Flow imaging on aortic flow physiology after valve-sparing root replacement with or without neosinuses†. Interact Cardiovasc Thorac Surg. 2018;26(6):957–64.CrossRefPubMed
21.
Zurück zum Zitat Cave DGW, Panayiotou H, Bissell MM. Hemodynamic profiles before and after surgery in bicuspid aortic valve disease—a systematic review of the literature. Front Cardiovasc Med. 2021;8:629227.CrossRefPubMedCentralPubMed Cave DGW, Panayiotou H, Bissell MM. Hemodynamic profiles before and after surgery in bicuspid aortic valve disease—a systematic review of the literature. Front Cardiovasc Med. 2021;8:629227.CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat Søndergaard L, Ihlemann N, Capodanno D, Jørgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73(5):546–53.CrossRefPubMed Søndergaard L, Ihlemann N, Capodanno D, Jørgensen TH, Nissen H, Kjeldsen BJ, et al. Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 2019;73(5):546–53.CrossRefPubMed
23.
Zurück zum Zitat Spadaccio C, Nappi F, Al-Attar N, Sutherland FW, Acar C, Nenna A, et al. Old myths, new concerns: the long-term effects of ascending aorta replacement with dacron grafts. Not all that glitters is gold. J Cardiovasc Transl Res. 2016;9(4):334–42.CrossRefPubMed Spadaccio C, Nappi F, Al-Attar N, Sutherland FW, Acar C, Nenna A, et al. Old myths, new concerns: the long-term effects of ascending aorta replacement with dacron grafts. Not all that glitters is gold. J Cardiovasc Transl Res. 2016;9(4):334–42.CrossRefPubMed
Metadaten
Titel
Distal aortic biomechanics after transcatheter versus surgical aortic valve replacement: a hypothesis generating study
verfasst von
Lisa Q. Rong
William Zheng
Andrew Martinez
Mohammed Rahouma
Richard B. Devereux
Jiwon Kim
Bassam Osman
Maria C. Palumbo
Björn Redfors
Leonard N. Girardi
Jonathan W. Weinsaft
Mario Gaudino
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
Journal of Cardiothoracic Surgery / Ausgabe 1/2023
Elektronische ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-023-02467-z

Weitere Artikel der Ausgabe 1/2023

Journal of Cardiothoracic Surgery 1/2023 Zur Ausgabe

Real-World-Daten sprechen eher für Dupilumab als für Op.

14.05.2024 Rhinosinusitis Nachrichten

Zur Behandlung schwerer Formen der chronischen Rhinosinusitis mit Nasenpolypen (CRSwNP) stehen seit Kurzem verschiedene Behandlungsmethoden zur Verfügung, darunter Biologika, wie Dupilumab, und die endoskopische Sinuschirurgie (ESS). Beim Vergleich der beiden Therapieoptionen war Dupilumab leicht im Vorteil.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.